Pharmadrug Stock Today
| LMLLF Stock | USD 0.01 0.0005 4.63% |
Performance1 of 100
| Odds Of DistressOver 53
|
Pharmadrug is trading at 0.0103 as of the 23rd of November 2024. This is a 4.63 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.0103. Pharmadrug has 53 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. Equity ratings for Pharmadrug are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of October 2024 and ending today, the 23rd of November 2024. Click here to learn more.
Pharmadrug Inc. operates as a specialty pharmaceutical company. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. Pharmadrug operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.. The company has 355.63 M outstanding shares. More on Pharmadrug
Moving against Pharmadrug Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Pharmadrug Pink Sheet Highlights
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Pharmadrug [LMLLF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.97 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pharmadrug's market, we take the total number of its shares issued and multiply it by Pharmadrug's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Pharmadrug classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 355.63 M outstanding shares.
Pharmadrug has accumulated about 126.38 K in cash with (4.13 M) of positive cash flow from operations.
Check Pharmadrug Probability Of Bankruptcy
Ownership AllocationPharmadrug owns a total of 355.63 Million outstanding shares. Roughly 98.12 pct. of Pharmadrug outstanding shares are held by general public with 1.88 % owned by insiders and only 0.0 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Pharmadrug Ownership Details
Pharmadrug Risk Profiles
| Mean Deviation | 11.3 | |||
| Semi Deviation | 13.19 | |||
| Standard Deviation | 15.48 | |||
| Variance | 239.53 |
Pharmadrug Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Pharmadrug without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Pharmadrug Corporate Management
| Harry Resin | Pres Smart | Profile | |
| Paul Slyke | Chief Officer | Profile | |
| Daniel Cohen | Chairman CEO | Profile | |
| Keith CPA | Chief Officer | Profile |
Other Information on Investing in Pharmadrug Pink Sheet
Pharmadrug financial ratios help investors to determine whether Pharmadrug Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmadrug with respect to the benefits of owning Pharmadrug security.